Trastuzumab [clinicaltrials_resource:7c0c5124376db41ab328c7f8679b143f]
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic [clinicaltrials:NCT00003440]clinicaltrials:NCT00003612Trastuzumab in Treating Patients With Prostate Cancer [clinicaltrials:NCT00003740]Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [clinicaltrials:NCT00003881]Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 [clinicaltrials:NCT00003992]Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 [clinicaltrials:NCT00003995]Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer [clinicaltrials:NCT00004013]clinicaltrials:NCT00004067Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer [clinicaltrials:NCT00004163]Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [clinicaltrials:NCT00004856]Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 [clinicaltrials:NCT00004883]clinicaltrials:NCT00004888Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer [clinicaltrials:NCT00004925]Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 [clinicaltrials:NCT00004935]Trastuzumab in Treating Patients With Recurrent Osteosarcoma [clinicaltrials:NCT00005033]Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 [clinicaltrials:NCT00005635]Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [clinicaltrials:NCT00005831]Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer [clinicaltrials:NCT00005842]Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy [clinicaltrials:NCT00005857]Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas [clinicaltrials:NCT00005926]Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer [clinicaltrials:NCT00005970]clinicaltrials:NCT00006015Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00006089]Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer [clinicaltrials:NCT00006104]Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00006108]clinicaltrials:NCT00006110Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00006123]Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00006228]Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00006381]Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer [clinicaltrials:NCT00006825]Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer [clinicaltrials:NCT00009997]Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer [clinicaltrials:NCT00014430]Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [clinicaltrials:NCT00016276]clinicaltrials:NCT00016367Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 [clinicaltrials:NCT00019812]clinicaltrials:NCT00021255BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00022529]clinicaltrials:NCT00022672Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma [clinicaltrials:NCT00023998]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Trastuzumab [clinicaltrials_resource:7c0c5124376db41ab328c7f8679b143f]
Bio2RDF identifier
7c0c5124376db41ab328c7f8679b143f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7c0c5124376db41ab328c7f8679b143f
identifier
clinicaltrials_resource:7c0c5124376db41ab328c7f8679b143f
title
Trastuzumab
@en
type
label
Trastuzumab [clinicaltrials_resource:7c0c5124376db41ab328c7f8679b143f]
@en